Centiva Capital »

Scpharmaceuticals shares owned by Centiva Capital

Quarter-by-quarter ownership of Scpharmaceuticals (SCPH) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Scpharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Scpharmaceuticals held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scpharmaceuticals by Centiva Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $107k 19k 5.67

More positions owned by Centiva Capital

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Tesla Motors (TSLA)
Regeneron Pharmaceuticals Call Option (REGN)
Pdd Holdings Sponsored Ads (PDD)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Amazon (AMZN)
Kraneshares Trust Csi Chi Internet Put Option (KWEB)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)

View all positions for Centiva Capital

Top funds holding Scpharmaceuticals

OrbiMed Advisors
Rubric Capital Management
Weiss Asset Management LP[1
BlackRock
Vanguard Group
Tudor Investment Corporation
Morgan Stanley
Luther King Capital Management Corporation
Hsbc Holdings
Glazer Capital
Alpine Associates Management
Newtyn Management
Geode Capital Management
Nantahala Capital Management
State Street Corporation

View all funds holding Scpharmaceuticals